Economist Impact: Cell and Gene Therapy Summit

Dates Apr 24 - 25, 2023
Location
Radisson Collection Hotel, Grand Place Brussels
Grote Markt
1000 Brussel
Belgium
The Economist's cell and gene therapy event convenes stakeholders from a range of industries. These important decision-makers will advance the discussion on bringing transformative products into the market. Cell and gene therapies can be transformative in the battle against cancer, genetic disorders and rare diseases. Future market-leading therapies will provide a treatment solution for patients with limited options. Attendees will discover how healthcare systems and policies need to evolve to accommodate essential cell and gene therapies.
Dates Apr 24 - 25, 2023
Location
Radisson Collection Hotel, Grand Place Brussels
Grote Markt
1000 Brussel
Belgium

Highlights

  • Who should attend: Policymakers and regulatory bodies, payers and insurers, investors, medical practitioners and healthcare providers, nonprofits and patient advocacy groups.
  • A unique event: A commercial and policy-focused programme will differentiate this event from others where there is a tendency for programmes to be more focused on science rather than the systems of the industry. Policy and reimbursement are the most pressing issues for pharmaceutical companies. They will learn about them at this event.
  • And a timely event: In the UK, NICE expects to review 30 new cell and gene therapy products by 2023, and the FDA predicts that by 2025 there could be 15-20 on the market. By next Spring, a number of those will have moved through approval to distributions, and there will be lots of practical takeaways for attendees, including lessons learned.
  • Simplifying the chatter: Under the stewardship of The Economist editors, the event on cell and gene therapies will bring together key stakeholders and give attendees "need to know" insights for advancing cell and gene products in the market.
Last update: June 3, 2023